Altered Gene Expression in Morphologically Normal Epithelial Cells from Heterozygous Carriers of BRCA1 or BRCA2 Mutations

Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Cancer Prevention Research (Impact Factor: 5.27). 01/2010; 3(1):48-61. DOI: 10.1158/1940-6207.CAPR-09-0078
Source: PubMed

ABSTRACT We hypothesized that cells bearing a single inherited "hit" in a tumor suppressor gene express an altered mRNA repertoire that may identify targets for measures that could delay or even prevent progression to carcinoma. We report here on the transcriptomes of primary breast and ovarian epithelial cells cultured from BRCA1 and BRCA2 mutation carriers and controls. Our comparison analyses identified multiple changes in gene expression, in both tissues for both mutations, which were validated independently by real-time reverse transcription-PCR analysis. Several of the differentially expressed genes had been previously proposed as cancer markers, including mammaglobin in breast cancer and serum amyloid in ovarian cancer. These findings show that heterozygosity for a mutant tumor suppressor gene can alter the expression profiles of phenotypically normal epithelial cells in a gene-specific manner; these detectable effects of "one hit" represent early molecular changes in tumorigenesis that may serve as novel biomarkers of cancer risk and as targets for chemoprevention.

Download full-text


Available from: Kerry S Campbell, Jul 30, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: The frictional behavior of a C<sub>60</sub> monolayer film between graphite substrates is studied using a homebuilt surface force apparatus. The mean frictional force from the C<sub>60</sub> monolayers is estimated to be approximately 2 mN, which is one-fifth that of C<sub>60</sub> multilayer thin films. The C<sub>60</sub> monolayer films exhibit a low frictional force of 2 mN up to one hundred scans under a normal stress of 8 MPa, which indicates that the C<sub>60</sub> monolayer film is highly promising for use as a lubricant.
    Micromechatronics and Human Science, 2002. MHS 2002. Proceedings of 2002 International Symposium on; 02/2002
  • [Show abstract] [Hide abstract]
    ABSTRACT: This perspective on Bellacosa et al. (beginning on p. 48 in this issue of the journal) discusses the important biology of microscopically normal tissues in carriers of germ-line BRCA1 or BRCA2 mutations. The work of Bellacosa et al. is an important step toward discerning which pathways may be altered when one BRCA allele is inactivated.
    Cancer Prevention Research 01/2010; 3(1):12-5. DOI:10.1158/1940-6207.CAPR-09-0249 · 5.27 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: BRCA1 gene inactivation causes chromosomal instability, leading to rapid accumulation of chromosomal rearrangements and mutations. The loss of BRCA1 function due to either germline/somatic mutation or epigenetic silencing is observed in most high-grade serous carcinomas of the ovary. DNA ploidy and gene expression profile were used in order to compare gross genomic alteration and gene expression pattern between cases with BRCA1 loss through mutation, BRCA1 epigenetic loss, and no BRCA1 loss in cases of high-grade serous carcinoma with known BRCA1 and BRCA 2 status. Using image cytometry and oligonucleotide microarrays, we analyzed DNA ploidy, S-phase fraction and gene expression profile of 28 consecutive cases of ovarian high-grade serous adenocarcinomas, which included 8 tumor samples with BRCA1 somatic or germline mutation, 9 samples with promoter hypermethylation of BRCA1, and 11 samples with no BRCA1 loss. None had BRCA2 mutations. The prevalence of aneuploidy and tetraploidy was not statistically different in the three groups with different BRCA1 status. The gene expression profiles were also very similar between the groups, with only two genes showing significant differential expression when comparison was made between the group with BRCA1 mutation and the group with no demonstrable BRCA1 loss. There were no genes showing significant differences in expression when the group with BRCA1 loss through epigenetic silencing was compared to either of the other two groups. In this series of 28 high-grade serous carcinomas, gross genomic alteration characterized by aneuploidy did not correlate with BRCA1 status. In addition, the gene expression profiles of the tumors showed negligible differences between the three defined groups based on BRCA1 status. This suggests that all ovarian high-grade serous carcinomas arise through oncogenic mechanisms that result in chromosomal instability, irrespective of BRCA status; the molecular abnormalities underlying this in the BRCA intact tumors remains unknown.
    BMC Cancer 09/2010; 10:493. DOI:10.1186/1471-2407-10-493 · 3.32 Impact Factor
Show more